Meitar

Veracyte Announces Preliminary Full-Year 2023 Results, Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform

Retrieved on: 
Monday, January 8, 2024

The company also announced it has reached a definitive agreement to acquire C2i Genomics, Inc. a minimal residual disease (MRD) detection company, adding whole-genome MRD capabilities to its novel diagnostics platform and positioning Veracyte to expand its offerings along the cancer care continuum.

Key Points: 
  • The company also announced it has reached a definitive agreement to acquire C2i Genomics, Inc. a minimal residual disease (MRD) detection company, adding whole-genome MRD capabilities to its novel diagnostics platform and positioning Veracyte to expand its offerings along the cancer care continuum.
  • “We had an outstanding fourth quarter and finished 2023 with continued growth driven by our Afirma and Decipher businesses,” said Marc Stapley, Veracyte’s chief executive officer.
  • Morgan Stanley & Co. LLC is serving as financial advisor to Veracyte, and Fenwick & West LLP is serving as legal advisor.
  • Perella Weinberg Partners is serving as financial advisor to C2i Genomics, and Meitar is serving as legal advisor.

Nuvo Group Ltd., an FDA-Cleared Leading Innovator in Pregnancy Care, to Become a Public Company Via Business Combination with LAMF Global Ventures Corp. I

Retrieved on: 
Friday, August 18, 2023

Nuvo Group Ltd. (“Nuvo”), the creators of INVU by Nuvo™, an FDA-cleared remote pregnancy monitoring platform, and LAMF Global Ventures Corp.

Key Points: 
  • Nuvo Group Ltd. (“Nuvo”), the creators of INVU by Nuvo™, an FDA-cleared remote pregnancy monitoring platform, and LAMF Global Ventures Corp.
  • I (Nasdaq: LGVC, LGVCU, LGVCW) (“LAMF”), a publicly traded special purpose acquisition company, today announced that they have entered into a definitive business combination agreement.
  • Upon the closing of the transaction, which is expected in the first quarter of 2024, the combined public company is expected to be listed on Nasdaq.
  • We believe women’s health and pregnancy care has seen far too little investment and innovation to address these concerning trends.

Novidea Raises $50 Million in Series C Funding Led by Battery Ventures

Retrieved on: 
Wednesday, May 3, 2023

The funding round was led by Battery Ventures with participation from Cross Creek, both new investors, and the company's existing investors, Israel Growth Partners (IGP), KT Squared, and JAL Ventures.

Key Points: 
  • The funding round was led by Battery Ventures with participation from Cross Creek, both new investors, and the company's existing investors, Israel Growth Partners (IGP), KT Squared, and JAL Ventures.
  • Novidea will leverage the investment to continue its journey to becoming an industry leader and increase international market share.
  • "We are thrilled to welcome Battery Ventures and Cross Creek as our newest partners in this round of funding, along with our existing investors.
  • Advising on legal matters around the transaction were law firms Pearl Cohen for Novidea and Meitar for Battery Ventures.

Aviat Networks Proposes to Acquire Ceragon Networks for $2.80 Per Share in Cash

Retrieved on: 
Monday, June 27, 2022

AUSTIN, Texas, June 27, 2022 /PRNewswire/ -- Aviat Networks, Inc. (NASDAQ: AVNW) ("Aviat"), the leading expert in wireless transport solutions, today announced it has submitted a nonbinding proposal to acquire all the outstanding shares of Ceragon Networks Ltd. (NASDAQ: CRNT) ("Ceragon") that it does not already own for $2.80 per share in cash. Aviat holds more than 5% of Ceragon's outstanding shares as of June 24, 2022, making it Ceragon's third largest shareholder.

Key Points: 
  • "We have twice attempted to reasonably address concerns voiced by Ceragon, and have met only with delay and rejection.
  • Aviat and Ceragon have complementary product roadmaps, which will enable greater innovation, expand revenue opportunities and enhance addressable market capture.
  • Aviat and Ceragon customers will benefit from access to a wider array of best-in-class hardware and software solutions in more geographic locations.
  • Aviat intends to fund a transaction with Ceragon through cash on hand and debt financing from one or more relationship banks.

Valley National Bancorp to Acquire Bank Leumi USA Creating a Premier Commercial Bank With Unique, Sustainable and Diverse Growth Opportunities

Retrieved on: 
Thursday, September 23, 2021

NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Valley National Bancorp (Valley) (NASDAQ: VLY) and Bank Leumi Le-Israel Corporation (Leumi) announced today that they have entered into a definitive merger agreement whereby Valley will acquire Leumi, the US subsidiary of Bank Leumi Le-Israel B.M., and parent company of Bank Leumi USA (Bank Leumi).

Key Points: 
  • NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Valley National Bancorp (Valley) (NASDAQ: VLY) and Bank Leumi Le-Israel Corporation (Leumi) announced today that they have entered into a definitive merger agreement whereby Valley will acquire Leumi, the US subsidiary of Bank Leumi Le-Israel B.M., and parent company of Bank Leumi USA (Bank Leumi).
  • Bank Leumis fee income is primarily driven by cash management services for commercial customers, and investment management fees within Bank Leumis private bank.
  • As the principal subsidiary of Valley National Bancorp, Valley National Bank is a regional bank with approximately $41 billion in assets as of June 30, 2021.
  • Bank Leumi Le-Israel Corporation is the U.S.-based holding company for Bank Leumi USA, a New York state chartered bank offering a full range of commercial loan and deposit products.

Embracer enters into an agreement to acquire CrazyLabs

Retrieved on: 
Thursday, August 5, 2021

STOCKHOLM, Aug. 5, 2021 /PRNewswire/ -- Embracer Group AB ("Embracer")[1], has entered into an agreement to acquire 100 percent of the shares in CrazyLabs Ltd. ("CrazyLabs") from the current owners.

Key Points: 
  • STOCKHOLM, Aug. 5, 2021 /PRNewswire/ -- Embracer Group AB ("Embracer")[1], has entered into an agreement to acquire 100 percent of the shares in CrazyLabs Ltd. ("CrazyLabs") from the current owners.
  • "Crazylabs is exactly the type of company Embracer wants to join forces with.Sagi and team are extremely talented, driven and long term oriented.
  • CrazyLabs engages hundreds of external hyper-casual studios concurrently helping CrazyLabs concept, test, and scale their products.
  • With the acquisition of CrazyLabs, Embracer considerably increases its mobile business both in terms of revenues but also audience.